Back to search
FDAFDA · Food and drugs·Recall number D-0110-2018

Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10

Published December 27, 2017 · Recall initiated: December 18, 2017

Summary

FDA records drug Class III recall D-0110-2018, published December 27, 2017 and initiated December 18, 2017. Recalling firm: Osmotica Pharmaceutical Corp; Status: Terminated; Reported quantity: 10064 bottles; Lot: Lot #: 170027A, Exp. 02/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email if METHYLPHENIDATE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHYLPHENIDATE HYDROCHLORIDE
Manufacturer
Osmotica Pharmaceutical Corp
Distributor
Nationwide
UPC
0313811706109
Lot
Lot #: 170027A, Exp. 02/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10 recalled?

Yes. FDA published recall D-0110-2018 on December 27, 2017. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHYLPHENIDATE HYDROCHLORIDE. UPC: 0313811706109.